Research Papers
This database includes peer-reviewed publications authored by TB Alliance staff. Use the tags on the left to filter by subject, or search for a particular author or term using the search bar.
Tag: BPaL
Displaying 11 papers
Next-Generation Diarylquinolines Improve Sterilizing Activity of Regimens with Pretomanid and the Novel Oxazolidinone TBI-223 in a Mouse Tuberculosis Model
Publication: Antimicrobial Agents and Chemotherapy
3/2023
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis
Publication: PLOS Global Public Health
11/2022
Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis
Publication: New England Journal of Medicine
9/2022
Budgetary impact of using BPaL for treating extensively drug resistant tuberculosis
Publication: BMJ Global Health
1/2022
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
Publication: BMC Public Health
7/2021
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Publication: The New England Journal of Medicine
3/2020
Daily Dosing for Bedaquiline in Patients with Tuberculosis
Publication: Antimicrobial Agents and Chemotheraphy
10/2019
Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
Publication: Antimicrobial Agents and Chemotheraphy
8/2019
Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis
Publication: Antimicrobial Agents and Chemotheraphy
7/2019
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
Publication: Antimicrobial Agents and Chemotheraphy
4/2019